Who Paid My Doc
Klane White
Pediatric Orthopaedic Surgery Aurora, CO Medical Doctor
NPI 1821037912 CMS profile 443661
13123 E 16Th Ave, Aurora, CO 80045
General payments
$107,002
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$822,910
Through program year 2025, Klane White of Aurora, CO is reported in the CMS Open Payments database as having received $107,002 across 96 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $822,910 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 95th percentile of Pediatric Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $15,836 | 12 | |
| 2024 | General | $23,702 | 13 | |
| 2023 | General | $8,411 | 10 | |
| 2022 | General | $12,074 | 16 | |
| 2021 | General | $10,090 | 8 | |
| 2020 | General | $16,628 | 19 | |
| 2019 | General | $20,262 | 18 |
Beside peers
- Klane White
- Pediatric Orthopaedic Surgery median
- Middle half of Pediatric Orthopaedic Surgery
- National median
In program year 2025, general payments to Klane White were reported at $15,836. Among 495 Pediatric Orthopaedic Surgery profiles paid that year, the median was $271 and the middle half received between $89 and $1,158.
Show as a table
| Year | Klane White | Pediatric Orthopaedic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $20,262 | $355 | $117–$1,889 | $163 |
| 2020 | $16,628 | $290 | $62–$1,625 | $114 |
| 2021 | $10,090 | $628 | $75–$2,400 | $132 |
| 2022 | $12,074 | $427 | $115–$2,170 | $149 |
| 2023 | $8,411 | $265 | $98–$1,497 | $160 |
| 2024 | $23,702 | $255 | $84–$1,694 | $164 |
| 2025 | $15,836 | $271 | $89–$1,158 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
96 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Orthopaedic Surgery in Colorado
Scott Hoffinger
Pediatric Orthopaedic Surgery · Colorado Springs, CO
Jaren Riley
Pediatric Orthopaedic Surgery · Denver, CO
Stephanie Stopka
Pediatric Orthopaedic Surgery · Aurora, CO
Sumeet Garg
Pediatric Orthopaedic Surgery · Aurora, CO
Ryan Sefcik
Pediatric Orthopaedic Surgery · Aurora, CO
Julia Sanders
Pediatric Orthopaedic Surgery · Aurora, CO
Related records
Pediatric Orthopaedic Surgery in Colorado
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Orthopaedic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Colorado
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.